Search

Testosterone enanthate

As recent as 1 October 2018, the US FDA approved Antares Pharma Inc.'

Etorphine

A narcotic analgesic morphinan used as a sedative in veterinary practice. In certain countries, etorphine is classified as a Schedule 1 drug and hence, in these countries, it can be used legally only by health professionals and for resea...

ALTU-135

ALTU-135 has been granted orphan drug and fast-track designation as well as CMA Pilot 2 program status by the Food and Drug Administration (FDA).

Anthralin

Anthralin (1,8‐dihydroxy‐9anthrone, dithranol) is an older anti-psoriatic agent that was first synthesized as a derivative of chrysarobin, obtained from the araroba tree in Brazil over 100 years ago.

Edoxaban

In addition to once daily dosing, the benefits over warfarin also include significant reductions in hemorrhagic stroke and GI bleeding, and improved compliance, which is beneficial as many patients will

Panitumumab

Panitumumab was granted FDA approval on 27 September 2006.[L17663]

Brodalumab

Brodalumab was FDA approved in February, 2017 as Siliq for the treatment of moderate-to-severe plaque psoriasis.

Diiodohydroxyquinoline

Iodoquinol is not currently available in any FDA-approved products.

Bardoxolone methyl